Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an opportunity to former noteholders to invest in the company’s current capital raise. Juul Labs looks forward to continued pursuit of its mission to transition adult smokers away from cigarettes while combating underage use.
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.
December 19, 2023
Juul Labs has taken another important step in its path forward to introduce novel technologies that provide adult smokers an alternative to combustible cigarettes…